Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).
Breast Cancer Res Treat
; 119(2): 391-8, 2010 Jan.
Article
en En
| MEDLINE
| ID: mdl-19851858
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
/
Células Madre Hematopoyéticas
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Leucemia Mieloide
/
Pruebas Genéticas
/
Hematopoyesis
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Breast Cancer Res Treat
Año:
2010
Tipo del documento:
Article
País de afiliación:
Estados Unidos